BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic rats

Objectives: Nanoparticles can be employed to improve the therapeutic activity of natural products. Type 2 diabetes mellitus is a serious health condition that has spread like a "modern pandemic" worldwide. In the present study, we developed silver nanoparticles, Ag-NPs, with an aqueous ex...

Full description

Saved in:
Bibliographic Details
Main Authors: Mosaad, Yasser O. (Author) , Hussein, Mohammed Abdalla (Author) , Ateyya, Hayam (Author) , Hassan, Soha Ahmed (Author) , Wink, Michael (Author) , Gobba, Naglaa Abd El Khalik (Author) , Mohamed, Zahraa Nassar (Author)
Format: Article (Journal)
Language:English
Published: 2023
In: Current pharmaceutical biotechnology
Year: 2023, Volume: 24, Issue: 14, Pages: 1812-1826
ISSN:1873-4316
DOI:10.2174/1389201024666230313105049
Online Access:Verlag, lizenzpflichtig, Volltext: https://dx.doi.org/10.2174/1389201024666230313105049
Verlag, lizenzpflichtig, Volltext: https://www.eurekaselect.com/article/130114
Get full text
Author Notes:Yasser Omar Mosaad, Mohammed Abdalla Hussein, Hayam Ateyya, Soha Ahmed Hassan, Michael Wink, Naglaa Abd El Khalik Gobba and Zahraa Nassar Mohamed

MARC

LEADER 00000caa a2200000 c 4500
001 1860859259
003 DE-627
005 20240307051821.0
007 cr uuu---uuuuu
008 231006s2023 xx |||||o 00| ||eng c
024 7 |a 10.2174/1389201024666230313105049  |2 doi 
035 |a (DE-627)1860859259 
035 |a (DE-599)KXP1860859259 
035 |a (OCoLC)1425210800 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Mosaad, Yasser O.  |e VerfasserIn  |0 (DE-588)1293415898  |0 (DE-627)1850741271  |4 aut 
245 1 0 |a BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic rats  |c Yasser Omar Mosaad, Mohammed Abdalla Hussein, Hayam Ateyya, Soha Ahmed Hassan, Michael Wink, Naglaa Abd El Khalik Gobba and Zahraa Nassar Mohamed 
264 1 |c 2023 
300 |b Illustrationen 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 28. April 2023 
500 |a Gesehen am 06.10.2023 
520 |a  Objectives: Nanoparticles can be employed to improve the therapeutic activity of natural products. Type 2 diabetes mellitus is a serious health condition that has spread like a "modern pandemic" worldwide. In the present study, we developed silver nanoparticles, Ag-NPs, with an aqueous extract from Balanites aegyptiaca to investigate their antioxidant and anti-inflammatory activity in STZ-induced diabetic rats. Methods: Aqueous extracts of Balanites aegyptiaca seeds (BAAE) were used in the synthesis of BAAE-AgNPs, which were characterized using FTIR and TEM. Different doses of BAAE-AgNP (1/50 LD50; 29.4 mg/kg b.w. and 1/20 LD50: 73.5 mg/kg b.w.) were administered to STZ-induced diabetic rats to evaluate their potential antidiabetic activity. Results: FTIR spectral data indicated the presence of flavonoids and polyphenols in BAAEAgNPs. The size of the BAAE-AgNPs, determined by TEM examination, was 49.33 ± 7.59 nm, with a zeta potential of +25.37. BAAE-AgNPs were characterized by an LD50 value of 1470 mg/kg b.w. In diabetic rats, the daily oral administration of both doses of BAAE-AgNPs (29.4 and 73.5 mg/kg b.w.) for 12 weeks resulted in a significant improvement in body weight, insulin homeostasis, HbA1c, HDL-C, MDA, and pancreatic SOD, CAT, and GSH. They reduced plasma glucose, cholesterol, and triglycerides. This treatment also resulted in a significant decrease in pancreatic IL-6, p53, and TNF-α in diabetic rats. Furthermore, BAAE-AgNPs down-regulated pancreatic TGF-β1 and Akt gene expression in diabetic rats and resulted in a significant decrease in the regulation of hepatic GLUT-2, as well as an increase in the regulation of hepatic GK and pancreatic B-cl2 gene expression. The histopathological results obtained indicated that BAAEAgNPs improved pancreatic tissue metabolism by enhancing antioxidant enzymes, suppressing inflammatory cytokines, and scavenging free radicals. Conclusion: The findings implied that similar to the glibenclamide-treated groups, in the BAAEAgNPs treated group, the compromised antioxidant status normalized in STZ-induced diabetes. By scavenging free radicals, BAAE-Ag-NPs protected against lipid peroxidation while reducing the risk of complications from diabetes. Compared to the daily dose of 29.4 mg, the impact was more prominent at 73.5 mg. 
700 1 |a Hussein, Mohammed Abdalla  |e VerfasserIn  |4 aut 
700 1 |a Ateyya, Hayam  |e VerfasserIn  |4 aut 
700 1 |a Hassan, Soha Ahmed  |e VerfasserIn  |4 aut 
700 1 |a Wink, Michael  |d 1951-  |e VerfasserIn  |0 (DE-588)124618146  |0 (DE-627)363448519  |0 (DE-576)164659390  |4 aut 
700 1 |a Gobba, Naglaa Abd El Khalik  |e VerfasserIn  |4 aut 
700 1 |a Mohamed, Zahraa Nassar  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Current pharmaceutical biotechnology  |d Hilversum : Bentham Science Publ., 2000  |g 24(2023), 14, Seite 1812-1826  |h Online-Ressource  |w (DE-627)327962445  |w (DE-600)2044611-1  |w (DE-576)273880926  |x 1873-4316  |7 nnas  |a BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic rats 
773 1 8 |g volume:24  |g year:2023  |g number:14  |g pages:1812-1826  |g extent:15  |a BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic rats 
856 4 0 |u https://dx.doi.org/10.2174/1389201024666230313105049  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.eurekaselect.com/article/130114  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20231006 
993 |a Article 
994 |a 2023 
998 |g 124618146  |a Wink, Michael  |m 124618146:Wink, Michael  |d 160000  |d 160100  |e 160000PW124618146  |e 160100PW124618146  |k 0/160000/  |k 1/160000/160100/  |p 5 
999 |a KXP-PPN1860859259  |e 4381788133 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Yasser Omar Mosaad, Mohammed Abdalla Hussein, Hayam Ateyya, Soha Ahmed Hassan, Michael Wink, Naglaa Abd El Khalik Gobba and Zahraa Nassar Mohamed"]},"id":{"doi":["10.2174/1389201024666230313105049"],"eki":["1860859259"]},"recId":"1860859259","physDesc":[{"noteIll":"Illustrationen","extent":"15 S."}],"origin":[{"dateIssuedDisp":"2023","dateIssuedKey":"2023"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 15.04.2024"],"id":{"zdb":["2044611-1"],"eki":["327962445"],"issn":["1873-4316"]},"part":{"volume":"24","year":"2023","issue":"14","extent":"15","text":"24(2023), 14, Seite 1812-1826","pages":"1812-1826"},"title":[{"title_sort":"Current pharmaceutical biotechnology","title":"Current pharmaceutical biotechnology","subtitle":"the international journal for timely in-depth reviews in pharmaceutical biotechnology"}],"origin":[{"dateIssuedDisp":"2000-","dateIssuedKey":"2000","publisherPlace":"Hilversum","publisher":"Bentham Science Publ."}],"pubHistory":["1.2000 -"],"disp":"BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic ratsCurrent pharmaceutical biotechnology","physDesc":[{"extent":"Online-Ressource"}],"recId":"327962445"}],"person":[{"given":"Yasser O.","role":"aut","family":"Mosaad","display":"Mosaad, Yasser O."},{"display":"Hussein, Mohammed Abdalla","family":"Hussein","given":"Mohammed Abdalla","role":"aut"},{"family":"Ateyya","given":"Hayam","role":"aut","display":"Ateyya, Hayam"},{"family":"Hassan","given":"Soha Ahmed","role":"aut","display":"Hassan, Soha Ahmed"},{"family":"Wink","role":"aut","given":"Michael","display":"Wink, Michael"},{"given":"Naglaa Abd El Khalik","role":"aut","family":"Gobba","display":"Gobba, Naglaa Abd El Khalik"},{"display":"Mohamed, Zahraa Nassar","family":"Mohamed","given":"Zahraa Nassar","role":"aut"}],"title":[{"title_sort":"BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic rats","title":"BAAE-AgNPs improve symptoms of diabetes in STZ-induced diabetic rats"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Online veröffentlicht: 28. April 2023","Gesehen am 06.10.2023"]} 
SRT |a MOSAADYASSBAAEAGNPSI2023